Review old bone, new tricks
- PMID: 35907112
- DOI: 10.1007/s10585-022-10176-5
Review old bone, new tricks
Abstract
Despite the significant progress made over the past decade with combination of molecular profiling data and the development of new clinical strategies, our understanding of metastasis remains elusive. Bone metastasis is a complex process and a major cause of mortality in breast and prostate cancer patients, for which there is no effective treatment to-date. The current review summarizes the routes taken by the metastatic cells and the interactions between them and the bone microenvironment. We emphasize the role of the specified niches and cues that promote cellular adhesion, colonization, prolonged dormancy, and reactivation. Understanding these mechanisms will provide better insights for future studies and treatment strategies for bone metastatic conditions.
Keywords: Bone metastasis; Breast cancer; Dormancy; Endosteal niche; Perivascular niche; Reactivation.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer.Cancer Commun (Lond). 2019 Nov 21;39(1):76. doi: 10.1186/s40880-019-0425-1. Cancer Commun (Lond). 2019. PMID: 31753020 Free PMC article. Review.
-
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.Bone. 2015 Sep;78:81-6. doi: 10.1016/j.bone.2015.04.046. Epub 2015 May 5. Bone. 2015. PMID: 25952970 Free PMC article.
-
Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.Neoplasia. 2012 May;14(5):429-39. doi: 10.1596/neo.111740. Neoplasia. 2012. PMID: 22745589 Free PMC article.
-
Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.Curr Cancer Drug Targets. 2015;15(6):469-80. doi: 10.2174/1568009615666150506092443. Curr Cancer Drug Targets. 2015. PMID: 25968899 Review.
-
Molecular Mechanisms of Bone Metastasis.Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):1-12. Cancer Genomics Proteomics. 2016. PMID: 26708594 Review.
References
-
- Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca J, Verron E Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.International journal of molecular sciences. 2018 Jan4,;19(1):148
-
- Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L et al (2017) Bone metastases: an overview. Oncol reviews 11(1):321
-
- Zhang W, Bado I, Wang H, Lo H, Zhang XH- (2019 Feb) Bone Metastasis: Find Your Niche and Fit in. Trends in Cancer 5(2):95–110
-
- Kalluri R, Weinberg RA (2009 Jun) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420–1428
-
- Marusyk A, Polyak K (2010) Tumor heterogeneity: Causes and consequences. Biochimica et biophysica acta. Reviews on cancer 1805(1):105–117
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous